Vascular & Endovascular

This channel includes news on non-coronary vascular disease and therapies. These include peripheral artery disease (PAD), abdominal and thoracic aortic aneurysm (AAA and TAA), aortic dissection, pulmonary embolism (PE), critical limb ischemia (CLI), carotid artery and stroke interventions, venous interventions, deep vein thrombosis (DVT), and interventional radiology therapies. The focus on most of these therapies is minimally invasive, catheter-based procedures performed in a cath lab.

Thumbnail

Distal radial access consistently lowers risk of artery occlusion during PCI

The new meta-analysis, published in the American Journal of Cardiology, includes data from 16 different studies. 

Thumbnail

Researchers review PCI outcomes, find little evidence of a ‘July effect’ in interventional cardiology

New trainees may not necessarily lead to a higher risk of medical errors during PCI.

Examples of CT imaging showing aortic dissections on an acute AAA response team app that was recently cleared by the FDA from Viz.AI.

FDA Roundup: AAA EVAR recommendations, key approvals in stroke care and interventional cardiology

The FDA has been busy, sharing recommendations and clearing solutions that could have a significant impact on cardiovascular care throughout the United States. 

Thumbnail

Cardiologists identify 162 genes responsible for coronary heart disease

The team's findings, one researcher said, "could eventually make a huge impact on many patients lives."

AstraZeneca COVID-19 vaccine slightly increases risk of blood clots

Researchers emphasized that the benefits of the vaccine still far outweigh the risks. 

Ticagrelor alone after DAPT lowers bleeding risk among heart attack patients undergoing PCI

Researchers examined data from the TWILIGHT study to track how different treatment strategies can impact 12-month PCI outcomes. 

The Bard Venovo venous stent

Office-based cath lab setting proves safe for iliac vein stenting

Iliac vein stunting procedures performed in out-patient office-based labs are associated with low complication rates.

Polymer-free amphilimus-eluting stents comparable to drug-eluting stents—and offer a potential advantage

The team's evaluation included data from four different randomized controlled trials

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.